Abstract:

Debilitation is a common syndrome of the elderly, and its core feature is the decline of the reserve function of multiple physiological systems (neuromuscular, endocrine and immune systems, etc.), which is manifested by an increase in susceptibility to the body and a decrease in homeostasis. This kind of elderly people often coexist with some chronic non-fatal diseases. Diabetes is one of the most common chronic diseases among the elderly. The disability and premature death caused by acute and chronic complications seriously affect the survival time and quality of life of patients. In addition, China is the country with the largest number of patients with diabetes in the world. Among them, type 2 diabetes accounts for more than 90.0%, and the prevalence of type 2 diabetes in the elderly over 60 years accounts for more than 20%. With the growth of age and progress of the disease, on the one hand, elderly diabetic patients will suffer from muscle loss and impairment of endurance, exercise ability and balance ability. On the other hand, they are often in a state of multiple disease coexistence. A systematic review of the relationship between debilitating and adverse outcomes in patients with diabetes suggests that debilitation can increase adverse outcomes such as falls, hospital admission, and death among elderly diabetic patients. Early effective interventions can prevent debilitating or delay the process of debilitation. Thereby, it can also reduce the adverse clinical outcomes of them. International researchers have paid attention to the monitoring and evaluation of the debilitation patients, and conducted a large number of investigations on the problem of diabetes mellitus combined with debilitation. The incidence of debilitation in diabetic patients ranged from 28.8% to 60.9%. According to the systematic search literature analysis, it is found that there are few reports on the weakening of the domestic focus on senile diabetes, which is still in its infancy. In view of this, it is necessary to understand and explore the debilitating status and influencing factors of elderly patients with type 2 diabetes in China, and provide reference and basis for further targeted intervention in the debilitation of elderly patients with type 2 diabetes.